ROCKVILLE, Md. , May 6, 2021 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced it will present at the following May investor conferences, which will each be held in a virtual meeting format:
Bank of America Securities 2021 Virtual Health Care Conference Day
Fireside Chat: Wednesday, May 12, 2021 at 12:30 p.m. E.T.
RBC Capital Markets 2021 Global Healthcare Virtual Conference
Fireside Chat: Tuesday, May 18, 2021 at 10:55 a.m. E.T.
UBS Global Healthcare Virtual Conference
Fireside Chat: Tuesday, May 25, 2021 at 11:00 a.m. E.T.
A live webcast of each fireside chat can be accessed in the 'Investors' section of REGENXBIO's website at www.regenxbio.com . An archived replay of each webcast will be available on the same website for approximately 30 days following each fireside chat.
About REGENXBIO Inc.
REGENXBIO is a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. REGENXBIO's NAV Technology Platform, a proprietary adeno-associated virus (AAV) gene delivery platform, consists of exclusive rights to more than 100 novel AAV vectors, including AAV7, AAV8, AAV9 and AAVrh10. REGENXBIO and its third-party NAV ® Technology Platform Licensees are applying the NAV Technology Platform in the development of a broad pipeline of candidates in multiple therapeutic areas.
Contacts:
Tricia Truehart
Investor Relations and Corporate Communications
347-926-7709
ttruehart@regenxbio.com
Investors:
Brendan Burns , 212-600-1902
brendan@argotpartners.com
Media:
David Rosen , 212-600-1902
david.rosen@argotpartners.com
View original content to download multimedia: http://www.prnewswire.com/news-releases/regenxbio-to-present-at-upcoming-investor-conferences-301285276.html
SOURCE REGENXBIO Inc.